Moody National Bank Trust Division Takes $740,000 Position in Acadia Healthcare Company, Inc. $ACHC

Moody National Bank Trust Division acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 25,063 shares of the company’s stock, valued at approximately $740,000.

Several other hedge funds and other institutional investors have also bought and sold shares of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Acadia Healthcare in the first quarter worth approximately $1,600,000. Goldman Sachs Group Inc. boosted its holdings in Acadia Healthcare by 21.1% in the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares during the last quarter. American Century Companies Inc. grew its position in Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after purchasing an additional 88,995 shares during the period. Finally, Prudential Financial Inc. lifted its holdings in shares of Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after buying an additional 1,780 shares during the period.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock opened at $32.24 on Thursday. The stock has a market cap of $3.00 billion, a P/E ratio of -2.59, a P/E/G ratio of 10.28 and a beta of 0.64. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The stock’s fifty day moving average is $28.71 and its 200 day moving average is $24.22. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same quarter in the previous year, the company posted $0.83 earnings per share. Acadia Healthcare’s revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on ACHC. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. Barclays boosted their price target on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. Royal Bank Of Canada increased their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Finally, KeyCorp raised their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.